Reduced-function CYP1C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCi: A meta-analysis
Mega, J. L. et al. reduced-function CYP1C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCi: a meta-analysis. JAMA 304, 1821-1830 (2010).
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TriTOn-TiMi 38 trial: A pharmacogenetic analysis
Mega, J. L. et al. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TriTOn-TiMi 38 trial: a pharmacogenetic analysis. Lancet 376, 1312-1319 (2010).
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: A genetic substudy of the PLaTO trial
Wallentin, L. et al. effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLaTO trial. Lancet 376, 1320-1328 (2010).
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes
Bassand, J. P et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J. 28, 1598-1660 (2007).
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the american College of Cardiology
American Heart association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction) developed in collaboration with the american College of emergency Physicians, the Society for Cardiovascular angiography and interventions, and the Society of Thoracic Surgeons, endorsed by the american association of Cardiovascular and Pulmonary rehabilitation and the Society for academic emergency Medicine
Anderson, J. L. et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the american College of Cardiology/american Heart association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction) developed in collaboration with the american College of emergency Physicians, the Society for Cardiovascular angiography and interventions, and the Society of Thoracic Surgeons, endorsed by the american association of Cardiovascular and Pulmonary rehabilitation and the Society for academic emergency Medicine. J. Am. Coll. Cardiol. 14, e1-e157 (2007).
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: A meta-analysis of individual patient data
Fox, K. A. A. et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: a meta-analysis of individual patient data. J. Am. Coll. Cardiol. 55, 2435-2445 (2010).
National institute for Health and Clinical excellence [online]
National institute for Health and Clinical excellence. Unstable angina and nSTeMi: the early management of unstable angina and non-ST-segment-elevation myocardial infarction. Clinical guideline 94 [online], http://www.nice.org.uk/ nicemedia/live/12949/47988/47988.pdf (2010)
FDa drug safety communication. reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug [online], http://www.fda.gov/Drugs/DrugSafety/Postm arketDrugSafetyinformationforPatients- andProviders/ucm203888.htm (2010).
